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To the Editor:
The article in a recent issue of the Turkish Journal of
Medical Sciences by Çakır Gürbüz et al. (1) is of high interest.
It deals with a relevant and still current topic, considering the
percentage of failure of noninvasive ventilation (NIV) related to
poor interface tolerance (2).
There are few points of this study that need to be addressed.
The first point concerns the severity of the airways
obstruction in the two groups. We can imagine that the level of
obstruction was severe or very severe, according to the initial
arterial blood gases reported, and that it was superimposable in
the two groups. However, this is not specified and, if statistically
different in the two groups, it might have had a role in the
different response to NIV. Also, baseline characteristics of the
patients such as chronic obstructive pulmonary disease (COPD)
phenotypes, chronic treatments, and acute administration of
antibiotics, which were not specified in the text, could have
played an analogous crucial role. (Incidentally, in Table 1 the
percentage of comorbidity in Group H is 64% and not 24%).
The second point refers to the ventilator setting. It is
reported that pressure support was gradually increased during
the first hour of ventilation “to observe adequate patient
respiratory effort”. As it is not described, we can deduce that
balloon catheters were not used to estimate the inspiratory
effort. Therefore, if the evaluation were only clinical, it would
have been more appropriate to speak of respiratory rate
reduction and accessory muscle activity disappearance, instead
of effort change. Furthermore, it is described that, after the
initial adjustment, the NIV setting was kept the same in the
two groups. It was demonstrated previously (3,4) that if helmet
and mask are used with the same pressure settings, the former
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induces a greater inspiratory muscle effort and significantly
worse patient–ventilator asynchrony, which could lead to
worse arterial blood gases outcomes. On the contrary, helmetspecific NIV settings were shown to improve inspiratory muscle
unloading and asynchronies to the level obtained with the
facemask (3).
Therefore, the higher initial partial carbon dioxide pressure
(pCO2) values in the helmet group are probably attributable
more to a less efficient reduction of the inspiratory effort,
due to a partial dissipation of the inspiratory pressure by the
intrinsic elastic characteristics of the helmet, rather than to
CO2 rebreathing (5). This event appears particularly remarkable
in the first hours of acute exacerbation of COPD, when the
ventilatory demand is increased (6).
In our opinion it is not clearly expressed how the trend of
respiratory rate (RR) and pCO2 changed throughout the study
period. Since neither data nor graphics concerning RR are
reported, it is not evident if there were significant differences
between the groups throughout the study period. Also,
concerning the pCO2 values, it is reported that “There was no
difference between groups in terms of pCO2 level among the
whole study period” but, at the same time, that pCO2 at 60 min
of NIV was statistically different from the baseline in one group
and not in the other.
The third point deals with the criteria to discontinue NIV.
No criteria are supplied. Furthermore, pH at the discontinuation
of NIV was rather low (according to Figure 3). Therefore, how
can we interpret the affirmation “The NIMV success rate was
quite high” in both groups? Are the authors only referring to a
reduction in hospital mortality or length of ICU stay?
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To the Editor:
We want to thank to Schreiber and Esquinas for their interest
and careful analysis of our recent study comparing the helmet
and facial mask during noninvasive ventilation (NIV) in patients
with acute exacerbation of chronic obstructive pulmonary
disease (COPD) (1). NIV is an option for the treatment of COPD
exacerbation. NIV via nasal-facial mask or helmet is a choice of
therapy for the treatment of acute COPD exacerbation (2).
Regarding severity of the airway obstruction and patients’
characteristics, we evaluated the acute obstruction level and
treatment plan according to the Global Initiative for Chronic
Obstructive Lung Disease criteria (3). In patients with severe
acute respiratory failure (pH < 7.25), the rate of NIV failure
was inversely related to the severity of respiratory acidosis. This
indicates that severe acidosis resulting from acute exacerbation is
a relevant predictor for treatment failure of NIV (4). In the present
study, overall pH values were higher than 7.25 in both groups.
Although we evaluated the baseline characteristics of the patients
during admission to the intensive care unit, it would be better to
specify these data in the text as Schreiber and Esquinas stated.
Regarding adequacy of inspiratory effort for the ventilatory
setting, respiratory rate and accessory muscles activity were used
in evaluating the inspiratory effort during NIV (2,5). In this study
References

we followed the diminishing of respiratory rate and accessory
muscle activity by observing adequate patient respiratory effort.
Even if evaluation of respiratory rate and accessory muscle
activity were performed, we agree with Schreiber and Esquinas
about clearly using these parameters in our text. We meant that
the pCO2 level was not different when we compared the groups,
but in the face-mask group the pCO2 level was significantly
decreased according to baseline values.
Antonelli et al. (2) performed a study in which they used
pressure support at 15–20 cmH2O in acute exacerbation of
COPD patients. We applied a similar pressure support level to
achieve reduced respiratory rate and accessory muscle activity in
the first hour, and we achieved the desired target effect in terms
of reducing inspiratory effort in both groups.
Regarding discontinuation of NIV, it was continued until
patients were discharged from the intensive care unit, even if the
study was terminated 48 h after it began. The pH level was low at
the 48th hour of study, but it was higher in both groups according
to baseline values. Success of the NIV was evaluated by using pH,
pCO2, and PO2 levels; clinical findings and observations; and
requirements for invasive mechanical ventilation.
Thanks again to Schreiber and Esquinas for their valuable
comments and contributions to our study.
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